Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Rubinstein

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Digestive Diseases and Sciences|December 5, 2018
Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness?Federico Piñero, Fernando Rubinstein, Sebastián Marciano, et al.
Annals of Hepatology|May 5, 2019
Liver transplantation in adults with acute liver failure: Outcomes from the Argentinean Transplant RegistryManuel Mendizabal, Viviana Tagliafichi, Fernando Rubinstein, et al.
European Journal of Gastroenterology & Hepatology|March 7, 2018
Adherence to Barcelona Clinic Liver Cancer therapeutic algorithm for hepatocellular carcinoma in the daily practice: a multicenter cohort study from ArgentinaFederico Piñero, Sebastián Marciano, Nora Fernández, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 22, 2024
Clinical impact of gender and age at onset on disease trajectory in primary progressive multiple sclerosis patientsSebastian Camerlingo, Fernando Rubinstein, Maria Celia Ysrraelit, et al.
JHEP Reports : Innovation in Hepatology|April 1, 2022
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantationCharlotte Costentin, Federico Piñero, Helena Degroote, et al.
JHEP Reports : Innovation in Hepatology|January 24, 2023
AFP score and metroticket 2.0 perform similarly and could be used in a "within-ALL" clinical decision toolFederico Piñero, Charlotte Costentin, Helena Degroote, et al.
JHEP Reports : Innovation in Hepatology|September 6, 2021
International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteriaHelena Degroote, Federico Piñero, Charlotte Costentin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 6, 2020
Direct-Acting Antivirals and Hepatocellular Carcinoma: No Evidence of Higher Wait-List Progression or Posttransplant RecurrenceFederico Piñero, Ilka Boin, Aline Chagas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 2, 2020
Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral AgentsManuel Mendizabal, Federico Piñero, Ezequiel Ridruejo, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 11, 2020
Liver transplantation for hepatocellular carcinoma: impact of expansion criteria in a multicenter cohort study from a high waitlist mortality regionFederico Piñero, Margarita Anders, Ilka F Boin, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Digestive Diseases and Sciences|December 5, 2018
Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness?Federico Piñero, Fernando Rubinstein, Sebastián Marciano, et al.
Annals of Hepatology|May 5, 2019
Liver transplantation in adults with acute liver failure: Outcomes from the Argentinean Transplant RegistryManuel Mendizabal, Viviana Tagliafichi, Fernando Rubinstein, et al.
European Journal of Gastroenterology & Hepatology|March 7, 2018
Adherence to Barcelona Clinic Liver Cancer therapeutic algorithm for hepatocellular carcinoma in the daily practice: a multicenter cohort study from ArgentinaFederico Piñero, Sebastián Marciano, Nora Fernández, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 22, 2024
Clinical impact of gender and age at onset on disease trajectory in primary progressive multiple sclerosis patientsSebastian Camerlingo, Fernando Rubinstein, Maria Celia Ysrraelit, et al.
JHEP Reports : Innovation in Hepatology|April 1, 2022
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantationCharlotte Costentin, Federico Piñero, Helena Degroote, et al.
JHEP Reports : Innovation in Hepatology|January 24, 2023
AFP score and metroticket 2.0 perform similarly and could be used in a "within-ALL" clinical decision toolFederico Piñero, Charlotte Costentin, Helena Degroote, et al.
JHEP Reports : Innovation in Hepatology|September 6, 2021
International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteriaHelena Degroote, Federico Piñero, Charlotte Costentin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 6, 2020
Direct-Acting Antivirals and Hepatocellular Carcinoma: No Evidence of Higher Wait-List Progression or Posttransplant RecurrenceFederico Piñero, Ilka Boin, Aline Chagas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 2, 2020
Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral AgentsManuel Mendizabal, Federico Piñero, Ezequiel Ridruejo, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 11, 2020
Liver transplantation for hepatocellular carcinoma: impact of expansion criteria in a multicenter cohort study from a high waitlist mortality regionFederico Piñero, Margarita Anders, Ilka F Boin, et al.
Pageof 5